Publication | Open Access
Clinical efficacy and tolerability of direct-acting antivirals in elderly patients with chronic hepatitis C
22
Citations
29
References
2017
Year
DAAs with or without IFN and RBV in the standard recommended 12 or 24-week treatment regimens are effective, well tolerated, and may be safely extended to elderly patients infected with chronic hepatitis C.
| Year | Citations | |
|---|---|---|
Page 1
Page 1